• 1
    Spotila LD, Constantinou CD, Sereda L, Ganguly A, Riggs BL, Prockop DJ. Mutation in a gene for type I procollagen (COL1A2) in a woman with postmenopausal osteoporosis: evidence for phenotypic and genotypic overlap with mild osteogenesis imperfecta. Proc Natl Acad Sci USA. 1991; 88: 54235427.
  • 2
    Shapiro JR, Stover ML, Burn VE, et al. An osteopenic nonfracture syndrome with features of mild osteogenesis imperfecta associated with the substitution of a cysteine for glycine at triple helix position 43 in the proα1(I) chain of type I collagen. J Clin Invest. 1992; 89: 567573.
  • 3
    Marini JC, Forlino A, Cabral WA, et al. Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans. Hum Mutat. 2007; 28: 209221.
  • 4
    Sillence DO, Senn A, Danks DM. Genetic heterogeneity in osteogenesis imperfecta. J Med Genet. 1979; 16: 101116.
  • 5
    Sillence DO, Rimoin DL, Danks DM. Clinical variability in osteogenesis imperfecta-variable expressivity or genetic heterogeneity. Birth Defects. 1979; 15: 113129.
  • 6
    Pihlajaniemi T, Dickson LA, Pope FM, et al. Osteogenesis imperfecta: cloning of a pro-α2(I) collagen gene with a frameshift mutation. J Biol Chem. 1984; 259: 1294112944.
  • 7
    Schwarze U, Hata R, McKusick VA, et al. Rare autosomal recessive cardiac valvular form of Ehlers-Danlos syndrome results from mutations in the COL1A2 gene that activate the nonsense-mediated RNA decay pathway. Am J Hum Genet. 2004; 74: 917930.
  • 8
    Harbers K, Kuehn M, Delius H, Jaenisch R. Insertion of retrovirus into the first intron of α1(I) collagen gene to embryonic lethal mutation in mice. Proc Natl Acad Sci USA. 1984; 81: 15041508.
  • 9
    Bonadio J, Saunders TL, Tsai E, et al. Transgenic mouse model of the mild dominant form of osteogenesis imperfecta. Proc Natl Acad Sci USA. 1990; 87: 71457149.
  • 10
    Jepsen KJ, Goldstein SA, Kuhn JL, Schaffler MB, Bonadio J. Type I collagen mutation compromises the post-yield behavior of Mov13 long bone. J Orthop Res. 1996; 14: 493499.
  • 11
    Khillan JS, Olsen AS, Kontusaari S, Sokolov B, Prockop DJ. Transgenic mice that express a mini-gene version of the human gene for type I procollagen (COL1A1) develop a phenotype resembling a lethal form of osteogenesis imperfecta. J Biol Chem. 1991; 266: 2337323379.
  • 12
    Pereira R, Khillan JS, Helminen HJ, Hume EL, Prockop DJ. Transgenic mice expressing a partially deleted gene for type I procollagen (COL1A1): a breeding line with a phenotype of spontaneous fractures and decreased bone collagen and mineral. J Clin Invest. 1993; 91: 709716.
  • 13
    Pereira RF, Hume EL, Halford KW, Prockop DJ. Bone fragility in transgenic mice expressing a mutated gene for type I procollagen (COL1A1) parallels the age-dependent phenotype of human osteogenesis imperfecta. J Bone Miner Res. 1995; 10: 18371843.
  • 14
    Forlino A, Porter FD, Lee EJ, Westphal H, Marini JC. Use of the Cre/lox recombination system to develop a non-lethal knock-in murine model for osteogenesis imperfecta with an α1(I) G349C substitution: variability in phenotype in BrtlIV mice. J Biol Chem. 1999; 274: 3792337931.
  • 15
    Kuznetsova NV, Forlino A, Cabral WA, Marini JC, Leikin S. Structure, stability and interactions of type I collagen with GLY349-CYS substitution in α1(I) chain in a murine osteogenesis imperfecta model. Matrix Biol. 2004; 23: 101112.
  • 16
    Kozloff KM, Carden A, Bergwitz C, et al. Brittle IV mouse model for osteogenesis imperfecta IV demonstrates postpubertal adaptations to improve whole bone strength. J Bone Miner Res. 2004; 19: 614622.
  • 17
    Uveges TE, Collin-Osdoby P, Cabral WA, et al. Cellular mechanism of decreased bone in Brtl mouse model of OI: imbalance of decreased osteoblast function and increased osteoclasts and their precursors. J Bone Miner Res. 2008; 23: 19831994 .
  • 18
    Chipman SD, Sweet HO, McBride DJ Jr, et al. Defective proα2(I) collagen synthesis in a recessive mutation in mice: a model of human osteogenesis imperfecta. Proc Natl Acad Sci USA. 1993; 90: 17011705.
  • 19
    McBride DJ Jr, Choe V, Shapiro JR, Brodsky B. Altered collagen structure in mouse tail tendon lacking the α2(I) chain. J Mol Biol. 1997; 270: 275284.
  • 20
    McBride DJ Jr, Shapiro JR, Dunn MG. Bone geometry and strength measurements in aging mice with the oim mutation. Calcif Tissue Int. 1998; 62: 172176.
  • 21
    Camacho NP, Hou L, Toledano TR, et al. The material basis for reduced mechanical properties in oim mice bones. J Bone Miner Res. 1999; 14: 264272.
  • 22
    Nicholls AC, Osse G, Schloon HG, et al. The clinical features of homozygous α2(I) collagen deficient osteogenesis imperfecta. J Med Genet. 1984; 21: 257262.
  • 23
    Deak SB, van der Rest M, Prockop DJ. Altered helical structure of a homotrimer of α1(I)chains synthesized by fibroblasts from a variant of osteogenesis imperfecta. Coll Relat Res. 1985; 5: 305313.
  • 24
    McBride DJ, Shapiro JR, Streeten EA, Shuldiner AR. Identification of COL1A2 mutation in the Old Order Amish. In: VII International Conference on Osteogenesis Imperfecta, 1999. 46.
  • 25
    Carter DR, Bouxsein ML, Marcus R. New approaches for interpreting projected bone densitometry data. J Bone Miner Res. 1992; 7: 137145.
  • 26
    Bachrach LK, Hastie T, Wang MC, Narasimhan B, Marcus R. Bone mineral acquisition in healthy Asian, Hispanic, black, and Caucasian youth: a longitudinal study. J Clin Endocrinol Metab. 1999; 84: 47024712.
  • 27
    Forlino A, Kuznetsova NV, Marini JC, Leikin S. Selective retention and degradation of molecules with a single mutant α1(I) chain in the Brtl IV mouse model of OI. Matrix Biol. 2007; 26: 604614.
  • 28
    Kuznetsova NV, McBride DJ, Leikin S. Changes in thermal stability and microunfolding pattern of collagen helix resulting from the loss of α2(I) chain in osteogenesis imperfecta murine. J Mol Biol. 2003; 331: 191200.
  • 29
    Brown LB, Streeten EA, Shapiro JR, et al. Genetic and environmental influences on bone mineral density in pre- and post-menopausal women. Osteoporos Int. 2005; 16: 18491856.
  • 30
    Streeten EA, McBride DJ, Pollin TI, et al. Quantitative trait loci for BMD identified by autosome-wide linkage scan to chromosomes 7q and 21q in men from the Amish Family Osteoporosis Study. J Bone Miner Res. 2006; 21: 14331442.
  • 31
    Ganguly A, Rock MJ, Prockop DJ. Conformation-sensitive gel electrophoresis for rapid detection of single-base differences in double-stranded PCR products and DNA fragments: evidence for solvent-induced bends in DNA heteroduplexes. Proc Natl Acad Sci USA. 1993; 90: 1032510329.
  • 32
    Korkko J, Annunen S, Pihlajamaa T, Prockop DJ, Ala-Kokko L. Conformation sensitive gel electrophoresis for simple and accurate detection of mutations: comparison with denaturing gradient gel electrophoresis and nucleotide sequencing. Proc Natl Acad Sci USA. 1998; 95: 16811685.
  • 33
    Korkko J, Milunsky J, Prockop DJ, Ala-Kokko L. Use of conformation sensitive gel electrophoresis to detect single-base changes in the gene for COL10A1. Hum Mutat. 1998; 1: S201203.
  • 34
    Agarwala R, Schaffer AA, Tomlin JF. Towards a complete North American anabaptist genealogy: II. Analysis of inbreeding. Hum Biol. 2001; 73: 533545.
  • 35
    Agarwala R, Biesecker LG, Schaffer AA. Anabaptist genealogy database. Am J Med Genet C Semin Med Genet. 2003; 121: 3237.
  • 36
    Agarwala R, Biesecker LG, Hopkins KA, Francomano CA, Schaffer AA. Software for constructing and verifying pedigrees within large genealogies and an application to the Old Order Amish of Lancaster County. Genome Res. 1998; 8: 211221.
  • 37
    Miles CA, Sims TJ, Camacho NP, Bailey AJ. The role of the α2 chain in the stabilization of the collagen type I heterotrimer: a study of the type I homotrimer in oim mouse tissues. J Mol Biol. 2002; 321: 797805.
  • 38
    Leikina E, Mertts MV, Kuznetsova N, Leikin S. Type I collagen is thermally unstable at body temperature. Proc Natl Acad Sci USA. 2002; 99: 13141318.
  • 39
    Kraybill DB. and Center for American Places. The Riddle of Amish Culture. Baltimore: Johns Hopkins University Press, 2001; xvi.
  • 40
    Zionts LE, Nash JP, Rude R, Ross T, Stott NS. Bone mineral density in children with mild osteogenesis imperfecta. J Bone Joint Surg Br. 1995; 77: 143147.
  • 41
    Lund AM, Molgaard C, Muller J, Skovby F. Bone mineral content and collagen defects in osteogenesis imperfecta. Acta Paediatr. 1999; 88: 10831088.
  • 42
    Kok DJ, Uiterwaal CS, Van Dongen AJ, et al. The interaction between Sillence type and BMD in osteogenesis imperfecta. Calcif Tissue Int. 2003; 73: 441445.
  • 43
    Lund AM, Muller J, Skovby F. Anthropometry of patients with osteogenesis imperfecta. Arch Dis Child, 1999; 80: 524528.
  • 44
    Heaney RP, Abrams S, Dawson-Hughes B, et al. Peak bone mass. Osteoporos Int. 2000; 11: 9851009.
  • 45
    Saggese G, Bertelloni S, Baroncelli GI, Di Nero G. Serum levels of carboxyterminal propeptide of type I procollagen in healthy children from 1st year of life to adulthood and in metabolic bone diseases. Eur J Pediatr. 1992; 151: 764768.
  • 46
    Trivedi P, Risteli J, Risteli L, Hindmarsh PC, Brook CG, Mowat AP. Serum concentrations of the type I and III procollagen propeptides as biochemical markers of growth velocity in healthy infants and children and in children with growth disorders. Pediatr Res. 1991; 30: 276280.
  • 47
    van der Sluis IM, Hop WC, van Leeuwen JP, Pols HA, de Muinck Keizer-Schrama SM. A cross-sectional study on biochemical parameters of bone turnover and vitamin d metabolites in healthy dutch children and young adults. Horm Res. 2002; 57: 170179.
  • 48
    Shao H, Burrage LC, Sinasac DS, et al. Genetic architecture of complex traits: large phenotypic effects and pervasive epistasis. Proc Natl Acad Sci USA. 2008; 105: 1991019914.
  • 49
    Roschger P, Fratzl-Zelman N, Misof BM, Glorieux FH, Klaushofer K, Rauch F. Evidence that abnormal high bone mineralization in growing children with osteogenesis imperfecta is not associated with specific collagen mutations. Calcif Tissue Int. 2008; 82: 263270.
  • 50
    Nadeau JH. Modifier genes in mice and humans. Nat Rev Genet. 2001; 2: 165174.
  • 51
    DiPetrillo K, Wang X, Stylianou IM, Paigen B. Bioinformatics toolbox for narrowing rodent quantitative trait loci. Trends Genet. 2005; 21: 683692.
  • 52
    Wang X, Ishimori N, Korstanje R, Rollins J, Paigen B. Identifying novel genes for atherosclerosis through mouse-human comparative genetics. Am J Hum Genet. 2005; 77: 115.